Ataxia
======

* J.A. Brunberg

Ataxia is manifested by a wide-based unsteady gait, errors of extremity trajectory or placement, errors in motor sequence or rhythm and/or by dysarthria.1 Tone is usually decreased and stretch reflexes may be “pendular.” Nystagmus, skew deviation, disconjugate saccades, and altered ocular pursuit can be present. Truncal instability and tremor of the body or head may occur, especially with cerebellar midline disorders.1

Ataxia can arise from disorders that involve cerebellum, spinal cord, brain stem, vestibular nuclei, thalamic nuclei, cerebral white matter, cortex (especially frontal), and peripheral sensory nerves. Because symptoms and signs are difficult to localize, imaging may be extensive and complex.

Disorders causing ataxia are numerous and often uncommon and recommendations for imaging are imprecise. The purpose here is to categorize the disorders that present with ataxia, and to suggest imaging objectives. Clinical and family history, physical findings and laboratory studies are essential.

For basic imaging purposes ataxia is approached on the basis of symptoms, age at onset, potential disease mechanism, and urgency for excluding disorders that requires immediate management. The ACR Appropriateness Criteria on Ataxia is summarized below.

## Classification of Disorders Causing Ataxia

### Mass Lesions

In pediatric patients the most common posterior fossa lesions are medulloblastoma, cystic astrocytoma, ependymoma, and brain stem glioma. In adults; hemangioblastomas, choroid plexus papillomas, extra-axial meningiomas, and metastatic processes become more prevalent. Frontal lobe and thalamic mass lesions can present with ataxia. MR imaging, without and with contrast, is superior to CT for these disorders.

Lhermitte-Duclos disease (dysplastic gangliocytoma) is a benign cerebellar hamartoma .2 Symptoms relate to local mass effect. MR imaging demonstrates a nonenhancing mass involving cortex and folia, with increased T2 signal intensity (SI) and internal curvilinear lower intensity bands.2 The mass may demonstrate restricted diffusion.2

Paraneoplastic cerebellar degeneration is characterized by acute or subacute ataxia, dysarthria, and ocular dysmetria.3 It usually occurs with breast, gynecologic, and lung tumors, or with Hodgkin disease.3 Antineuronal antibodies are identified in serum. MR imaging is generally normal until late, when cerebellar cortical atrophy becomes evident.3 Uncommonly, there is increased T2 SI in cerebellar or other areas. Evaluation for an underlying primary is necessary.

### Vascular Disorders

Hemorrhage or infarction localized to the cerebellum, lateral medulla or pons, mesencephalon, red nucleus, thalamic nuclei, posterior limb of the internal capsule, or to frontal or parietal cortex can result in ataxia.4 Syndromes associated with infarction5 in the posterior inferior cerebellar artery territory (lateral medullary or Wallenberg syndrome) include ipsilateral hemiataxia, vertigo, dysarthria, ptosis, and miosis. Evaluation generally requires MR imaging, diffusion characterization and MR angiography. Neck vessel MR imaging may exclude dissection.6 MR venography helps when central or dural venous thrombosis is considered. Catheter-based and/or CT angiography (CTA) is occasionally necessary.

In superficial siderosis hemosiderin accumulates in subpial brain and spinal cord as the result of recurrent, often silent, subarachnoid hemorrhage. Symptoms include slowly progressive ataxia and hearing loss.7 MR imaging shows low superficial T2 SI over cortex, brain stem, and/or spinal cord with usual cerebellar atrophy.

### Infectious and Postinfectious Processes

Bacterial cerebellitis can occur with meningitis, penetrating trauma or extension of an epidural process, most commonly from temporal bone. Diffusion imaging and MR spectroscopy narrow the differential diagnosis.8 Viral processes, including herpes and arborvirus, can also involve brain stem or cerebellum.9

Prion-associated encephalopathies include sporadic Creutzfeldt-Jakob disease (sCJD), variant Creutzfeldt-Jakob disease (vCJD) or bovine spongiform encephalopathy, and familial Creutzfeldt-Jakob disease (fCJD). sCJD and vCJD present with behavioral, emotional, and intellectual deterioration, followed by ataxia and dysarthria. Progression is to stupor and coma. MR imaging demonstrates increased T2 SI and diffusion-weighted SI in the heads of the caudate nuclei, the putamen, and in regions of frontal, parietal, and occipital cortex. Findings can initially be asymmetric.10 There is eventual diffuse volume loss. While all forms of CJD can have increased T2 SI and restricted diffusion in the thalamic nuclei and pulvinar, this alteration is prominent in vCJD.10

Acute cerebellitis (acute cerebellar ataxia) is a para-infectious disorder, predominately of childhood. Symptoms include headache, ataxia, photophobia, and increased intracranial pressure. MR imaging demonstrates mass effect and increased cerebellar T2 SI.11 Lateral ventricle enlargement, upward herniation and meningeal enhancement may occur. Follow-up imaging may demonstrate cerebellar atrophy.12

Bickerstaff encephalitis is a postviral brain stem and cerebellar inflammation with ataxia and ophthalmoplegia. MR imaging demonstrates brain stem and cerebellar mass effect with increased T2 SI.13

Fisher syndrome, a Guillain-Barré variant, involves the peripheral and central nervous system. Ophthalmoplegia and ataxia are associated with transient high T2 SI in the cerebellum and/or brain stem.14 Cranial nerves and spinal nerve root enhancement can be seen with increased T2 SI in posterior spinal cord.15 There is late cerebellar atrophy.

### Trauma

Gait instability may persist following cerebellar, vestibular, brain stem, or frontal lobe injury or with interruption of the frontopontocerebellar tract.16 In acute trauma, or progressive post-traumatic ataxia, an expanding cyst or extra-axial hematoma should be considered.

### Demyelinating Disorders

Ataxia is common in early and late multiple sclerosis. MR findings have been reviewed.17

### Congenital Disorders

Dandy Walker Syndrome, with ataxia, nystagmus, cranial nerve palsies, apneic episodes, hydrocephalus, and cognitive dysfunction, demonstrates hypoplasia of the cerebellar vermis and a CSF collection that is predominately posterior to the cerebellum but continuous with the fourth ventricle.18 The torcula is usually elevated and the posterior fossa enlarged. Hydrocephalus is common, and anomalies of cerebral development may involve cortex and corpus callosum.18 Differentiation from congenital or acquired posterior fossa cysts is essential.

Joubert syndrome, with congenital ataxia, hypotonia, and oculomotor ataxia, has unique imaging alterations that include a “molar tooth” contour of brain stem and “bat wing” configuration of the fourth ventricle.19 There are 4 sub-types with variable clinical and imaging features, and with differing genetic alterations.20

Rhombencephalosynapsis is a rare cerebellar dysplastic process that can occur alone or in association with other developmental anomalies. There is vermian agenesis, fusion of the cerebellar hemispheres, and fusion of the superior cerebellar peduncles. Lateral ventricles are usually enlarged, and there may be fusion of the thalamic nuclei. Symptoms are variable.

Ataxia can also occur with perinatal cerebral infarction and with congenital CNS infection.18,21 Ataxic cerebral palsy is uncommon and imaging findings are variable.22

### Hereditary and Idiopathic Degenerative Processes

Hereditary ataxias are classified by the causative gene (when known) and their pattern of inheritance. MR imaging is preferred. A broad range of diagnoses is often suggested by family history, by findings on physical examination, and MR evidence of atrophy involving cerebellum and varying combinations of the pons, medulla, spinal cord, cerebral cortex and optic nerves. Dentate calcification may be identified. Definitive diagnosis relies on molecular genetic testing. While ataxia is the identifying clinical finding, spasticity, neuropathy, seizures, extrapyramidal symptomatology, cognitive decline, nystagmus, visual loss, spasmodic cough, and migrainelike episodes may be associated.

Among autosomal dominant spinocerebellar ataxias (AD-SCAs), specific diagnostic nomenclature is replacing terms like “spinocerebellar degeneration,” “Marie's ataxia,” and OPCA. Among AD-SCA disorders, 22 genetic abnormalities have been identified. “OPCA” is now used only for cases with a combination of “cerebellar-plus” symptomatology, imaging correlates of cerebellar and brain stem atrophy, and an unidentified genetic basis.23 “Idiopathic late onset cerebellar ataxia” is used to describe a different large group of adults with predominant cerebellar symptomatology, absence of a family history, and absence of an identified genetic marker.24 Imaging generally demonstrates cerebellar and pontine volume loss.

Other genetic and sporadic neurodegenerative disorders need to be considered in the evaluation of slowly progressive ataxia. AD SCAs also include SCA2, SCA3 (Machado-Joseph disease), and Dentorubral-pallidolusian atrophy (DRPLA).25 Autosomal recessive disorders associated with ataxia include Friedreich's ataxia and Ataxia-telangiectasia (A-T).26–28 An x-linked disorder, Fragile X tremor/ataxia syndrome (FXTAS), has recently been described.29–31 Multiple system atrophy (MSA) is a sporadic disorder that initially manifests after age 50 by ataxia (MSAc) or Parkinsonism (MSAp).29,32 Mitochondrial disorders are also associated with progressive ataxia, with coenzyme Q deficiency and an early childhood leukoencephalopathy known as vanishing white matter disease being examples. Clinical and imaging findings on these disorders are further characterized in the ACR Appropriateness Criteria on Ataxia ([www.acr.org/ac](http://www.acr.org/ac)).

### Paroxysmal Disorders Associated with Ataxia

Intermittent ataxia has been associated with epilepsy, migraine, and high systemic fever in otherwise healthy children. Intermittent ataxia can also be associated with abnormalities in membrane calcium or potassium channel function, or with altered synaptic glutamate transport.33,34 MR imaging may be normal, may demonstrate cerebellar volume loss, or may demonstrate areas of cortical increased T2 SI that may correlate with the possible simultaneous occurrence of hemiplegic migraine or recent seizure activity. MR imaging is the technique of choice.

### Spinal Cord and Peripheral Nerve-Related Ataxia

Spinal cord and/or nerve root disorders can produce ataxia. High resolution T1 and T2 axial and sagittal imaging, without and with contrast needs to focus on posterior columns and on nerve roots. In pernicious anemia there may be early localized or relatively diffuse cord swelling with increased T2 SI that is most evident in the posterior columns.35 Late atrophy and persistent gliosis may develop, or all findings may resolve with treatment.35 In the presence of hypertrophic, inflammatory, or postinfectious polyneuropathies, nerve root enhancement and enlargement may be demonstrated with MR imaging.17

### Nutritional Deficiency, Toxins and Drugs

Solvent abuse or toxic exposure to solvents, methyl-mercury poisoning (Minamata disease), metronidazole (Flagyl)-induced cerebellar toxicity, central pontine myelinolysis (osmotic demyelination syndrome), leukoencephalopathy relating to the inhalation of heroin vapors, vitamin E deficiency, chronic ethanol abuse, Wernicke encephalopathy, and reversible posterior leukoencephalopathy can each be associated with the acute or chronic presentation of ataxia. In each of these disorders MR imaging is preferred. These disorders and their imaging are further characterized in the published ACR Appropriateness Criteria on Ataxia ([www.acr.org/ac](http://www.acr.org/ac)).

## Appendix

Expert Panel on Neurologic Imaging: James A. Brunberg, MD, Principal Author, University of California-Davis Medical Center, Sacramento, Calif; David J. Seidenwurm, MD, Panel Chair; Patricia C. Davis, MD; Robert L. DeLaPaz, MD; Pr. Didier Dormont; David B. Hackney, MD; John E. Jordan, MD; John P. Karis, MD; Suresh Kumar Mukherji, MD; Patrick A. Turski, MD; Franz J. Wippold II, MD; Robert D. Zimmerman, MD; Michael W. McDermott, MD, American Association of Neurological Surgeons; Michael A. Sloan, MD, MS, American Academy of Neurology.

## Footnotes

*   This article is a summary of the complete version of this topic, which is available on the ACR Website at [www.acr.org/ac](http://www.acr.org/ac). Referral to the complete version is encouraged.

*   Reprinted with permission of the American College of Radiology.

## References

1.  Gilman S, Gelb DJ. **Disorders of the cerebellum.** In: Griggs RC, Joynt RJ, eds. Baker's Clinical Neurology: Lippincott Williams & Wilkins,2003
    
    

2.  Abel TW, Baker SJ, Fraser MM, et al. **Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway.** J Neuropathol Exp Neurol 2005;64:341–49
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=15835270&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

3.  Bruylant K, Crols R, Humbel RL, et al. **Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.** Clin Neurol Neurosurg 2006;108:415–17
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/j.clineuro.2005.01.008&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16644410&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

4.  Kataoka S, Hori A, Shirakawa T, et al. **Paramedian pontine infarction. Neurological/topographical correlation.** Stroke 1997;28:809–15
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjI4LzQvODA5IjtzOjQ6ImF0b20iO3M6MjA6Ii9ham5yLzI5LzcvMTQyMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

5.  Cormier PJ, Long ER, Russell EJ. **MR imaging of posterior fossa infarctions: vascular territories and clinical correlates.** Radiographics 1992;12:1079–96
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=1439013&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1992JY36500003&link_type=ISI) 

6.  Shah GV, Quint DJ, Trobe JD. **Magnetic resonance imaging of suspected cervicocranial arterial dissections.** J Neuroophthalmol 2004;24:315–18
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=15662248&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

7.  Kumar N, Cohen-Gadol AA, Wright RA, et al. **Superficial siderosis.** Neurology 2006;66:1144–52
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToibmV1cm9sb2d5IjtzOjU6InJlc2lkIjtzOjk6IjY2LzgvMTE0NCI7czo0OiJhdG9tIjtzOjIwOiIvYWpuci8yOS83LzE0MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

8.  Garg M, Gupta RK, Husain M, et al. **Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy.** Radiology 2004;230:519–27
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=14699181&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

9.  Kato Z, Kozawa R, Teramoto T, et al. **Acute cerebellitis in primary human herpesvirus-6 infection.** Eur J Pediatr 2003;162:801–03
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s00431-003-1287-7&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=12942319&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000186279800014&link_type=ISI) 

10. Mendonca RA, Martins G, Lugokenski R, et al. **Subacute spongiform encephalopathies.** Top Magn Reson Imaging 2005;16:213–19
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1097/01.rmr.0000191427.25176.1b&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16340337&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

11. De Bruecker Y, Claus F, Demaerel P, et al. **MRI findings in acute cerebellitis.** Eur Radiol 2004;14:1478–83
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=14968261&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

12. Adachi M, Kawanami T, Ohshima H, et al. **Cerebellar atrophy attributed to cerebellitis in two patients.** Magn Reson Med Sci 2005;4:103–07
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.2463/mrms.4.103&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16340165&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

13. Mondejar RR, Santos JM, Villalba EF. **MRI findings in a remitting-relapsing case of Bickerstaff encephalitis.** Neuroradiology 2002;44:411–14
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s00234-001-0733-3&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=12012126&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000176070500007&link_type=ISI) 

14. Suzuki K, Meguro K, Nakayama J, et al. **MRI of an infant with Fisher syndrome.** Childs Nerv Syst 1997;13:95–96
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s003810050051&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=9105745&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 

15. Inoue N, Ichimura H, Goto S, et al. **MR imaging findings of spinal posterior column involvement in a case of Miller Fisher syndrome.** AJNR Am J Neuroradiol 2004;25:645–48
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo4OiIyNS80LzY0NSI7czo0OiJhdG9tIjtzOjIwOiIvYWpuci8yOS83LzE0MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

16. Terry JB, Rosenberg RN. **Frontal lobe ataxia.** Surg Neurol 1995;44:583–88
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/0090-3019(95)00302-9&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=8669037&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1995TX87100030&link_type=ISI) 

17. Ge Y. **Multiple sclerosis: the role of MR imaging.** AJNR Am J Neuroradiol 2006;27:1165–76
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo5OiIyNy82LzExNjUiO3M6NDoiYXRvbSI7czoyMDoiL2FqbnIvMjkvNy8xNDIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

18. Patel S, Barkovich AJ. **Analysis and classification of cerebellar malformations.** AJNR Am J Neuroradiol 2002;23:1074–87
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czo5OiIyMy83LzEwNzQiO3M6NDoiYXRvbSI7czoyMDoiL2FqbnIvMjkvNy8xNDIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

19. Alorainy IA, Sabir S, Seidahmed MZ, et al. **Brain stem and cerebellar findings in Joubert syndrome.** J Comput Assist Tomogr 2006;30:116–21
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1097/01.rct.0000191681.05473.13&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16365585&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000234532200022&link_type=ISI) 

20. Valente EM, Marsh SE, Castori M, et al. **Distinguishing the four genetic causes of Jouberts syndrome-related disorders.** Ann Neurol 2005;57:513–19
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1002/ana.20422&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=15786477&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000228053500007&link_type=ISI) 

21. Mercuri E, He J, Curati WL, et al. **Cerebellar infarction and atrophy in infants and children with a history of premature birth.** Pediatr Radiol 1997;27:139–43
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s002470050085&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=9028846&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1997WN68100010&link_type=ISI) 

22. Himmelmann K, Hagberg G, Beckung E, et al. **The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995–1998.** Acta Paediatr 2005;94:287–94
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1111/j.1651-2227.2005.tb03071.x&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16028646&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000228451300008&link_type=ISI) 

23. Berciano J, Boesch S, Perez-Ramos JM, et al. **Olivopontocerebellar atrophy: Toward a better nosological definition.** Mov Disord 2006;21:1607–13. Review.
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1002/mds.21052&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16874757&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000241745300005&link_type=ISI) 

24. Kerber KA, Jen JC, Perlman S, et al. **Late-onset pure cerebellar ataxia: differentiating those with and without identifiable mutations.** J Neurol Sci 2005;238:41–45
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/j.jns.2005.06.006&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16109427&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000233504900007&link_type=ISI) 

25. Koide R, Onodera O, Ikeuchi T, et al. **Atrophy of the cerebellum and brainstem in dentatorubral pallidoluysian atrophy. Influence of CAG repeat size on MRI findings.** Neurology 1997;49:1605–12
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToibmV1cm9sb2d5IjtzOjU6InJlc2lkIjtzOjk6IjQ5LzYvMTYwNSI7czo0OiJhdG9tIjtzOjIwOiIvYWpuci8yOS83LzE0MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

26. Bhidayasiri R, Perlman SL, Pulst SM, et al. **Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature.** Arch Neurol 2005;62:1865–69
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1001/archneur.62.12.1865&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=16344344&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000233827500009&link_type=ISI) 

27. Butch AW, Chun HH, Nahas SA, et al. **Immunoassay to measure ataxia-telangiectasia mutated protein in cellular lysates.** Clin Chem 2004;50:2302–08
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiY2xpbmNoZW0iO3M6NToicmVzaWQiO3M6MTA6IjUwLzEyLzIzMDIiO3M6NDoiYXRvbSI7czoyMDoiL2FqbnIvMjkvNy8xNDIwLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

28. Tavani F, Zimmerman RA, Berry GT, et al. **Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI.** Neuroradiology 2003;45:315–19
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=12740724&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000183398500009&link_type=ISI) 

29. Brunberg JA, Jacquemont S, Hagerman RJ, et al. **Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction.** AJNR Am J Neuroradiol 2002;23:1757–66
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiYWpuciI7czo1OiJyZXNpZCI7czoxMDoiMjMvMTAvMTc1NyI7czo0OiJhdG9tIjtzOjIwOiIvYWpuci8yOS83LzE0MjAuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

30. Hagerman RJ, Leehey M, Heinrichs W, et al. **Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.** Neurology 2001;57:127–30
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToibmV1cm9sb2d5IjtzOjU6InJlc2lkIjtzOjg6IjU3LzEvMTI3IjtzOjQ6ImF0b20iO3M6MjA6Ii9ham5yLzI5LzcvMTQyMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

31. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. **Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.** Cell 1991;65:905–14
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1016/0092-8674(91)90397-H&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=1710175&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1991FP51600020&link_type=ISI) 

32. Geser F, Wenning GK. **The diagnosis of multiple system atrophy.** J Neurol 2006;253 Suppl 3:iii2–iii15
    
    

33. Browne DL, Gancher ST, Nutt JG, et al. **Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.** Nat Genet 1994;8:136–40
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1038/ng1094-136&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=7842011&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=A1994PL12300014&link_type=ISI) 

34. Jen JC, Wan J, Palos TP, et al. **Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures.** Neurology 2005;65:529–34
    
    [Abstract/FREE Full Text](http://www.ajnr.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToibmV1cm9sb2d5IjtzOjU6InJlc2lkIjtzOjg6IjY1LzQvNTI5IjtzOjQ6ImF0b20iO3M6MjA6Ii9ham5yLzI5LzcvMTQyMC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

35. Bassi SS, Bulundwe KK, Greeff GP, et al. **MRI of the spinal cord in myelopathy complicating vitamin B12 deficiency: two additional cases and a review of the literature.** Neuroradiology 1999;41:271–74
    
    [CrossRef](http://www.ajnr.org/lookup/external-ref?access_num=10.1007/s002340050746&link_type=DOI) 
    
    [PubMed](http://www.ajnr.org/lookup/external-ref?access_num=10344513&link_type=MED&atom=%2Fajnr%2F29%2F7%2F1420.atom) 
    
    [Web of Science](http://www.ajnr.org/lookup/external-ref?access_num=000080044800008&link_type=ISI) 

View this table:
[Table1](http://www.ajnr.org/content/29/7/1420/T1)

**Clinical condition: ataxia** 

*   Copyright © American Society of Neuroradiology